Complex drug regimens, poor disease knowledge, and healthcare dissatisfaction are key drivers of non-adherence to anti-hypertensive therapy.
Answers are grounded in this paper and cite their sources.
Complex regimens, knowledge gaps, and dissatisfaction may drive non-adherence; cross-sectional data leave causality open for prospective trials.
OBJECTIVES: to identify the degree of knowledge of people with hypertension concerning the disease and to verify the factors associated with the non-adherence to anti-hypertensive drug therapy. METHOD: Cross sectional study, involving 422 people. Data collection took place at their homes, between December 2011 and March 2012, through interviews using the following instruments: Medication Adherence Questionnaire (MAQ-Q), Medication Regimen Complexity Index (MRCI) and a guide with questions related to sociodemographic profile, satisfaction with healthcare service and knowledge about the disease. RESULTS: 42.6% did not adhere to the drug therapy and 17.7% had poor knowledge about the disease. Factors associated with the non-adherence were: complex drug therapy, poor knowledge about the disease and dissatisfaction with the healthcare service. CONCLUSION: The findings reinforce that the complex drug therapy prescriptions, little knowledge about the disease and dissatisfaction with the healthcare service have influence on the process of non-adherence to anti-hypertensive drug therapy.
No takes yet. Share an insight, caveat, or question.
Barreto et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: